Genetic Signatures EasyScreen pathogen detection kits provides hospital and pathology laboratories with the molecular tools to screen for a wide array of infectious pathogens in a rapid high-throughput environment. Information about Genetic Signatures Initial Public Offering (IPO) and listing on the ASX can be found in the company's prospectus.